“…To the best of our knowledge, this is the first demonstration of an inhibitory effect for Cxs on the expression of c-Myc and cyclin D1 in the breast tissue. This effect has been reported in osteosarcoma, glioma, hepatoma, and lung carcinoma cells overexpressing Cx genes and is associated with reduced tumorigenicity [114,115,116,117]. Interestingly, T4-2 cells, the tumorigenic counterparts of S1 cells, did not show increased Wnt/β-catenin activity compared to S1 cells, suggesting the involvement of other signaling pathways.…”